SCHEMBL561857

SCHEMBL561857

CC(O)CC(Cl)(Cl)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3120245 1.00
Diethanolamine SCHEMBL11585335 0.81 TDP1 (0.32)
SCHEMBL220417 0.72
SCHEMBL10771052 0.72
SCHEMBL6645226 0.71 TSHR (0.36)
SCHEMBL8887908 0.71 CYP1A2 (0.42)
Propylene Glycol SCHEMBL29020315 0.69 TDP1 (0.71)
SCHEMBL4429855 0.69
SCHEMBL9230623 0.69
SCHEMBL443754 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024011218-A1 POLYMERIC NANOPARTICLES FOR LONG ACTING DELIVERY OF A PEPTIDE AND METHODS OF MAKING AND USING THEREOF BROWN UNIVERSITY (US) 2024-01-11 WO disclosed
US-11759458-B2 Indane-amines as PD-L1 antagonists CHEMOCENTRYX, INC. (US) 2023-09-19 US disclosed
EP-3564233-B1 1,4-DISUBSTITUTED PYRIDAZINE ANALOGS AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS NOVARTIS AG (CH) 2023-05-03 EP disclosed
EP-4101849-A1 1,4-DISUBSTITUTED PYRIDAZINE ANALOGS AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS Novartis AG (CH) 2022-12-14 EP disclosed
US-20220387428-A1 1,4-DISUBSTITUTED PYRIDAZINE ANALOGS THERE OF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS NOVARTIS AG (CH) 2022-12-08 US disclosed
US-20220175746-A1 INDANE-AMINES AS PD-L1 ANTAGONISTS CHEMOCENTRYX, INC. 2022-06-09 US disclosed
CN-114531850-A Pharmaceutical composition and kit characterized by containing novel penicillin derivative or salt thereof and 1 or more compounds selected from beta-lactamase inhibitory compound and antibacterial compound or salt thereof 富士胶片株式会社 2022-05-24 CN disclosed
CN-114316102-A Alkoxy magnesium carrier, polyethylene catalyst and preparation method thereof 北京吉海川科技发展有限公司 2022-04-12 CN disclosed
US-11229648-B2 1,4-disubstituted pyridazine analogs thereof and methods for treating SMN-deficiency-related conditions NOVARTIS AG (CH) 2022-01-25 US disclosed
EP-2885288-B1 1,4-DISUBSTITUTED PYRIDAZINE ANALOGS AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS NOVARTIS AG (CH) 2021-10-06 EP disclosed
US-4271262-A Photoimaging process which uses sulfide containing polymeric films MONSANTO COMPANY (US) 1981-06-02 US disclosed
US-4266004-A Photoimageable material of polymeric material having organic sulfide and photo-oxidation sensitizer MONSANTO COMPANY (US) 1981-05-05 US disclosed
EP-0020401-A1 IMPROVED PROCESS FOR THE SYNTHESIS OF 1,4-DIAZA-2-CYCLOALKANONE AND SUBSTITUTED DERIVATIVES THEREOF. GOODRICH CO B F (US) 1981-01-07 EP disclosed
EP-0020401-A4 IMPROVED PROCESS FOR THE SYNTHESIS OF 1,4-DIAZA-2-CYCLOALKANONE AND SUBSTITUTED DERIVATIVES THEREOF. GOODRICH CO B F (US) 1980-08-11 EP disclosed
WO-1980000702-A1 IMPROVED PROCESS FOR THE SYNTHESIS OF 1,4-DIAZA-2-CYCLOALKANONE AND SUBSTITUTED DERIVATIVES THEREOF GOODRICH CO B F (US) 1980-04-17 WO disclosed
EP-0007182-A1 Stabilized polymers, novel stabilizers and synthesis thereof The B.F. GOODRICH Company (US) 1980-01-23 EP disclosed
EP-0004460-A1 Improved synthesis of 1,4-diaza-2-cycloalkanone and substituted derivatives thereof The B.F. GOODRICH Company (US) 1979-10-03 EP disclosed
US-4110379-A FIRE RETARDANT MAKHTESHIM CHEMICAL WORKS LTD. (IL) 1978-08-29 US disclosed
US-4069173-A POLYCARBOXYLIC ACID ARMSTRONG CORK COMPANY (US) 1978-01-17 US disclosed
US-4045440-A ETHERIFICATION WITH METHYL IODIDE, OXIDATION WITH MANGANESE DIOXIDE THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH, EDUCATION AND WELFARE (US) 1977-08-30 US disclosed